ArticleFrontiers in oncology2018

Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response.

Hong Yuen Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.